Diabetes Archives - Page 126 of 128 - Renal and Urology News


Statin Helps Diabetics Who Have Low GFR

CHICAGO—Atorvastatin (Lipitor) is as effective in preventing major cardiovascular events in type 2 diabetics who have impaired renal function as it is in those with normal renal function, according to data presented here at the 67th Scientific Sessions of the American Diabetes Association.

Telmisartan Offers Better Renoprotection

CHICAGO—Telmisartan (Micardis HCT), a novel angiotensin receptor blocker (ARB), and the older ARB losartan have similar BP-lowering efficacy in hypertensive patients with diabetic nephropathy, but treatment with the new agent is associated with larger reductions in proteinuria, new findings show.

Mechanisms of Diabetic Nephropathy

The kidney consists of four basic tissue types: vessels, glomeruli, tubules, and interstitium. Each of these types may be influenced by different pathophysiologic mechanisms associated with diabetic nephropathy. Despite their variability, these mechanisms share common clinical outcomes including microalbuminuria, progesssion to end-stage renal disease, and increased risks of cardiovascular morbidity and mortality.

Expanded Use for Anti-Diabetes Injection Approved

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have announced that Byetta (exenatide) injection has been approved for expanded combination therapy in people with type 2 diabetes who have not achieved adequate blood sugar control on a thiazolidinedione (TZD).

Next post in News